12 months after Ireland's pharma sector was put squarely in the crosshairs of the global trade war, we have come out smiling and largely unscathed on the other side. It is now clear that the multinationals who established themselves in Ireland over the past half-century have become far too entrenched to be removed by the tariff threats from US President Donald Trump and his demands for companies to reshore operations back across the Atlantic.
This is exclusive subscriber content. Already a subscriber? Sign in
